Find a Pharmacy
Vertice Login
Menu
close
Info banner
A significant part of the Healthesystems vision is to create a more integrated experience for our customers
Info banner
A significant part of the Healthesystems vision is to create a more integrated experience for our customers

Transforming the workers’ compensation pharmacy and ancillary benefits management experience

Powered by state-of-the-art technology
Supported by human-centered service
Informed by industry expertise
Inspired by a commitment to care
blog

6 Complexities in Workers’ Comp Claims – and How to Address Them

Let’s look at common complexities in workers’ comp claims – and how a combination of technology, data, and people can help address them.
Read More
rxinformer

The Heart of the Matter: Pharmacy Considerations for Cardiovascular Comorbidities

128 million adults in the U.S. are affected by hypertension and cardiovascular diseases.
Read More
INDUSTRY SURVEY

2025 Industry Survey Report

This seventh annual survey report highlights the top challenges and priorities of 500 industry professionals.
Read More

Featured Videos

Personalize my experience

Make selections below to see articles and information related to your role and interests.

  • I am a

  • I'm interested in


Perspectives: Status Woe - Outdated Regulation Impedes Healthcare Innovation

Industry thought leaders share their insights

Winter 2018/2019


Shifting Gears in Patient Transportation with Rideshare

How rideshare models like Lyft and Uber can reduce costs and improve patient experience

Winter 2018/2019


Patient Engagement Is Personal: How to Help Injured Workers Help Themselves

Strategies for increasing patient engagement in recovery and associated outcomes

Winter 2018/2019


Opioid Imbalance: Risk Disparities Among Diverse Patient Populations

Population-based opioid risks include gender, socioeconomic status, and ethnicity

Winter 2018/2019


The Opioids Crisis: Our Defining Moment

Special commentary on the opioid crisis from our clinical leaders

Winter 2018/2019


Hero's Welcome: Growing PTSD Coverage for First Responders

Formulary and claims management considerations for populations at risk for PTSD

Winter 2018/2019


FDA Approves New Opioid, Dsuvia

Five-to-ten times stronger than fentanyl, this drug is not for consumer use, and many claim it could worsen the opioid crisis.

Nov 2018


The Opioid Crisis: Our Defining Moment

Healthesystems’ clinical leaders comment on the collective responsibility of healthcare entities, providers, and legislators to increase efforts that will help stem opioid overprescribing, misuse and overdose.

Nov 2018


Midterm Marijuana Updates

More states allow for the legalization of recreational and medical marijuana, while others consider insurance reimbursement.

Nov 2018


JAMA Examines Persistent Opioid Use in Workers’ Comp Patients

A study of 9,596 claimants who filled an opioid prescription found that 30% were still taking opioids 90 days later.

Nov 2018


Healthesystems at NWCDC 2018

Join our VP of Clinical Services on December 6th in Las Vegas for a presentation on value-based care in workers’ comp.

Nov 2018


DEA Reschedules Epidiolex

The marijuana-derived seizure drug now sits at schedule V, facing far fewer prescribing and dispensing restrictions.

Oct 2018


Dr. Silvia Sacalis Discusses Medication Red Flags with Risk & Insurance

Healthesystems’ VP of Clinical Services offers insight into prescriptions in workers’ comp claims that should raise concerns.

Oct 2018


New Jersey Bill Pushes for Medical Marijuana Reimbursement

Assembly No. 4505 may solidify precedence recently made by a judge from the Division of Workers’ Compensation.

Oct 2018


National Safety Council Issues Report on Workplace Fatigue

Common risk factors can increase worker fatigue, leading to more frequent workplace injuries and a loss of productivity.

Oct 2018


Federal Opioid Reform Bill Signed into Law

With an enormous range of initiatives to prevent and treat opioid use disorder, the bill has officially been signed by the President.

Oct 2018


FDA Approves New Dosage for Opioid Dependence Therapy

Cassipa (buprenorphine and naloxone) sublingual film delivers a new dosage for the treatment of opioid dependence.

Sep 2018


Dr. Silvia Sacalis Discusses Polypharmacy with WC Magazine

Healthesystems’ VP of Clinical Services explains how too many drugs in a claim can cause health concerns, and what can be done to prevent them.

Sep 2018


FDA Reassesses Opioid Policies

The FDA is working to create new opioid prescribing practices and guidelines, while also shifting drug development priorities for pain medications.

Sep 2018


CWCI Releases Polypharmacy Report

According to 2016-2017 data, over 20% of polypharmacy claims are over 10 years old, with more than 50% of them for patients aged 50 and older.

Sep 2018


Massachusetts Study Links Occupation to Opioid Overdose Deaths

On average, construction workers are six times more likely to die from an opioid overdose death, more than any other occupation.

Sep 2018


Dr. Robert Goldberg Comments on DEA Opioid Manufacturing Quotas

Healthesystems’ Chief Medical Officer spoke with WorkCompCentral regarding DEA plans to reduce opioid manufacturing.

Sep 2018


FDA Accepts New Drug Application for Opioid NKTR-181

NKTR-181 is supposed to offer a lower frequency of opioid side effects. But are more opioids really the solution we need to the opioid crisis?

Aug 2018


Sandy Shtab Discusses the Need to Modernize Regulation with WorkCompWire

Healthesystems’ AVP of Advocacy & Compliance explains how regulation has been unable to keep pace with healthcare innovation & technology.

Aug 2018


PTSD Legislation Continues to Grow

More states cover PTSD without physical injuries for first responders, and 24 states allow PTSD patients to use medical marijuana.

Aug 2018


New Developments in Migraine Medications

A new wave of drugs that suppress CGRP proteins to reduce migraines could be on the horizon.

Aug 2018


FDA Proposes New Clinical Endpoints for Development of Opioid-Use Disorder Drugs

Drugs to treat opioid dependence could be approved under new clinical endpoints other than reducing opioid use.

Aug 2018


Healthe Clinical Leaders in the News

Our Chief Medical Officer and VP of Clinical Services comment on matters such as the use of anticonvulsants to treat pain and opioid prescriptions for inpatients.

Aug 2018


New Opioid in Development May Offer Reduced Risk Profile

Phase 2/3 clinical trial results for Korsuva demonstrate pain relief with fewer side effects.

Jul 2018


Mark of the Millennial: Managed Care for a New Generation

Millennials are more diverse and more open to alternative therapies, medical marijuana, healthcare technology, and dialogue surrounding psychosocial concerns.

Jul 2018

1 2 3 4 5 … 18 19 20 21 22 23
lockmap-markermagnifiercrossmenuarrow-rightcross-circle